Cargando…

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

INTRODUCTION: Cytokeratin (CK) 14, one of several markers expressed in normal myoepithelial/basal cells, is also expressed in a proportion of breast carcinomas. Previous studies have suggested that expression of such 'basal' markers predicts different biological behaviour, with more freque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fulford, Laura G, Reis-Filho, Jorge S, Ryder, Ken, Jones, Chris, Gillett, Cheryl E, Hanby, Andrew, Easton, Douglas, Lakhani, Sunil R
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851397/ https://www.ncbi.nlm.nih.gov/pubmed/17217540 http://dx.doi.org/10.1186/bcr1636

Ejemplares similares

Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast
por: Millis, R R, et al.
Publicado: (2004)

The diagnosis and management of pre-invasive breast disease: Pathology of atypical lobular hyperplasia and lobular carcinoma in situ
por: Simpson, Peter T, et al.
Publicado: (2003)

CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation
por: Jones, C, et al.
Publicado: (2001)

The diagnosis and management of pre-invasive breast disease: Genetic alterations in pre-invasive lesions
por: Reis-Filho, Jorge S, et al.
Publicado: (2003)

Sloane Project: a prospective audit of screen detected ductal carcinoma in situ
por: Evans, A, et al.
Publicado: (2002)

IDO-1 inhibitor INCB24360 elicits distant metastasis of basal extruded cancer cells in pancreatic ductal adenocarcinoma
por: Buhe, Hada, et al.
Publicado: (2022)

Survival Outcomes in Invasive Lobular Carcinoma Compared to Oestrogen Receptor-Positive Invasive Ductal Carcinoma
por: Timbres, Jasmine, et al.
Publicado: (2021)

Morphometric grading of invasive ductal breast cancer. I. Thresholds for nuclear grade.
por: Kronqvist, P., et al.
Publicado: (1998)

Breast cancer prognostic classification in the molecular era: the role of histological grade
por: Rakha, Emad A, et al.
Publicado: (2010)

Functional characterization of the 19q12 amplicon in grade III breast cancers
por: Natrajan, Rachael, et al.
Publicado: (2012)

Incorporating tumour pathology information into breast cancer risk prediction algorithms
por: Mavaddat, Nasim, et al.
Publicado: (2010)

New Morphological Features for Grading Pancreatic Ductal Adenocarcinomas
por: Song, Jae-Won, et al.
Publicado: (2013)

MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours
por: Garcia-Dios, Diego A, et al.
Publicado: (2018)

Isolated Uterine Metastasis of Invasive Ductal Carcinoma
por: Arslan, Deniz, et al.
Publicado: (2013)

Pituitary metastasis of a breast ductal adenocarcinoma
por: EL Habnouny, J., et al.
Publicado: (2020)

Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast
por: Perez, Amanda Arantes, et al.
Publicado: (2013)

Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It?
por: Cserni, Gábor, et al.
Publicado: (2019)

Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane Project
por: Evans, A, et al.
Publicado: (2008)

A candidate metastasis-associated DNA marker for ductal mammary carcinoma
por: Achary, Patnala Mohan R, et al.
Publicado: (2003)

Mixed ductal‐lobular carcinomas: evidence for progression from ductal to lobular morphology
por: McCart Reed, Amy E, et al.
Publicado: (2018)

Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ
por: Aguiar, Fernando N., et al.
Publicado: (2013)

Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival
por: Lyu, Su Ir, et al.
Publicado: (2023)

Two cases of pancreatic ductal adenocarcinoma with intrapancreatic metastasis
por: Fujita, Yusuke, et al.
Publicado: (2016)

Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies
por: Ayres Pereira, Marina, et al.
Publicado: (2019)

Molecular Aspects of Breast Cancer Metastasis to the Brain
por: Saunus, Jodi M., et al.
Publicado: (2011)

Are triple-negative tumours and basal-like breast cancer synonymous?
por: Rakha, Emad A, et al.
Publicado: (2007)

Sonographic features of invasive ductal breast carcinomas predictive of malignancy grade
por: Gupta, Kanika, et al.
Publicado: (2018)

The predictive value of calcification for the grading of ductal carcinoma in situ in Chinese patients
por: Kong, Jianchun, et al.
Publicado: (2020)

Variability in grading of ductal carcinoma in situ among an international group of pathologists
por: van Seijen, Maartje, et al.
Publicado: (2021)

HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells
por: Ewers, Katharina M., et al.
Publicado: (2021)

p73 activates transcriptional signatures of basal lineage identity and ciliogenesis in pancreatic ductal adenocarcinoma
por: Hur, Stella K., et al.
Publicado: (2023)

Gradual Telomere Shortening and Increasing Chromosomal Instability among PanIN Grades and Normal Ductal Epithelia with and without Cancer in the Pancreas
por: Matsuda, Yoko, et al.
Publicado: (2015)

Fibroadenoma progress to ductal carcinoma in situ, infiltrating ductal carcinoma and lymph node metastasis? Report an unusual case
por: Wu, Yu-Ting, et al.
Publicado: (2017)

Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis
por: Zhang, Geng, et al.
Publicado: (2020)

Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers
por: Xu, Huiling, et al.
Publicado: (2011)

Infrequent Loss of Luminal Differentiation in Ductal Breast Cancer Metastasis
por: Calvo, Julia, et al.
Publicado: (2013)

Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
por: Buc, Emmanuel, et al.
Publicado: (2014)

Clinical management of grade III oligodendroglioma
por: Simonetti, G, et al.
Publicado: (2015)

Surgical correction of grade III hypertelorism
por: Haq, Ehtesham Ul, et al.
Publicado: (2017)

Differentiating Grade in Breast Invasive Ductal Carcinoma Using Texture Analysis of MRI
por: Yuan, Gaoteng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tsi05u2bnvknct3luf1vh2v9ft